Showing results (251-260 of 388) with videos related to

Sort By:
Pageof 39
Journal of Human Virology|April 9, 1999
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infectionN Berry, K Ariyoshi, S Jaffar, et al.
American Journal of Medical Genetics|December 1, 1993
Najjar syndrome revisitedI T Thomas, T Jewett, P Lantz, et al.
British Journal of Cancer|February 1, 1985
The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancerN Berry, D B Jones, J Smallwood, et al.
The Journal of Arthroplasty|December 27, 2005
Waiting for hip arthroplasty: economic costs and health outcomesJann M Fielden, J M Cumming, J G Horne, et al.
Human Reproduction (Oxford, England)|July 1, 1989
Quality control in an in-vitro fertilization laboratory: use of human sperm survival studiesJ D Critchlow, P L Matson, M C Newman, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 10, 2006
Medical optimisation can reduce morbidity and mortality associated with elective aortic aneurysm repairJ Dawson, S Vig, E Choke, et al.
Thrombosis and Haemostasis|January 1, 1996
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombinC Lunven, C Gauffeny, C Lecoffre, et al.
BMC Medical Ethics|December 18, 2019
Engaging people with lived experience in the grant review processKatherine Rittenbach, Candice G Horne, Terence O'Riordan, et al.
Nutrients|November 25, 2020
High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian HamstersRachael G Horne, Yijing Yu, Rianna Zhang, et al.
British Journal of Pharmacology|June 1, 1996
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparinN Duval, C Lunven, D P O'Brien, et al.
Pageof 39